Challenges and Opportunities for Co-Morbid Substance Use Disorder and Major Depressive Disorder

Description

Webinar: Challenges and Opportunities for Co-Morbid Substance Use Disorder and Major Depressive Disorder

Location: Online Via PsychU.org

Description: Approximately one third of patients with Major Depressive Disorder (MDD) also have a substance use disorder (SUD). Depending on the type of substance, a wide range of effects on MDD symptomatology can occur, particularly depending on where in the cycle of recovery from the SUD. In this webinar, Dr. Robin Nelson, MD and Dr. Roueen Rafeyan, MD will discuss the challenges and opportunities for treating co-morbid SUD in MDD, including the impact of different substances on the symptomatology of MDD.

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Event Speakers

Robin Nelson, M.D.
PsychU Major Depressive Disorder Section Advisor

• Psychiatrist, DGR Comprehensive Behavioral Health, LLC
• Medical Director, Caron Counseling Outpatient Services, Wyomissing, Pennsylvania

Roueen Rafeyan, MD
Psychiatrist, CMO for Gateway Foundation Addiction Treatment Centers, Chicago, IL

• Assistant Professor of Psychiatry Fienberg School of Medicine, Northwestern University, Chicago, IL
• Chosen Top Psychiatrist in the Nation by Consumer Reports 2007
• Distinguished Fellow of the APA 2010; Fellow of the America Society of Addiction